Arcellx, Inc.

ACLX · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
73
SEC Filings
$115.07
Close 2026-04-27

Business Summary

Arcellx, Inc. is a clinical-stage biotechnology company developing immunotherapies for cancer and other incurable diseases. Its proprietary D-Domain synthetic binding scaffold powers two therapeutic platforms: ddCARs (classical single-infusion CAR-Ts) and ARC-SparX (dosable, controllable universal CAR-Ts). Its lead product, anito-cel (anitocabtagene autoleucel), targets BCMA in relapsed/refractory multiple myeloma and has a BLA submitted to the FDA. The company also has programs in AML, MDS, and autoimmune diseases such as generalized Myasthenia Gravis.

Latest Stock Quote

ACLX 2026-04-27 $115.07 O:$115.04 H:$115.13 L:$114.99 Vol:16.1M VWAP:$115.0706
origin leaf: 218833203be4439d47444db985967bd4306f176a71e97f87789b4882434651ba

Next Earnings

Q2 FY2026 — expected 2026-08-07

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-02-262025-12-310001193125-26-076876EDGAR116K words
2025-02-272024-12-310000950170-25-029150EDGAR110K words
2024-02-282023-12-310000950170-24-022048EDGAR110K words
2023-03-292022-12-310000950170-23-010610EDGAR107K words
2022-03-242021-12-310000950170-22-004573EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-052025-09-300001193125-25-266932EDGAR63K words
2025-08-072025-06-300000950170-25-105064EDGAR62K words
2025-05-082025-03-310000950170-25-067100EDGAR60K words
2024-11-072024-09-300000950170-24-123442EDGAR63K words
2024-08-082024-06-300000950170-24-094120EDGAR62K words
2024-05-092024-03-310000950170-24-057007EDGAR60K words
2023-11-132023-09-300000950170-23-062930EDGAR77K words
2023-08-142023-06-300000950170-23-042402EDGAR76K words
2023-05-082023-03-310000950170-23-018782EDGAR72K words
2022-11-142022-09-300000950170-22-025099EDGAR—
2022-08-152022-06-300000950170-22-017455EDGAR—
2022-05-122022-03-310000950170-22-009732EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-02-230001193125-26-063955EDGAR52K words
2025-12-080001193125-25-311276EDGAR2K words
2025-11-050001193125-25-266866EDGAR1K words
2025-08-070000950170-25-105015EDGAR1K words
2025-05-280001193125-25-129522EDGAR1K words
2025-05-140001193125-25-119506EDGAR1K words
2025-05-080001193125-25-116023EDGAR2K words
2025-03-200001193125-25-058978EDGAR1K words
2025-02-270001193125-25-039316EDGAR2K words
2024-12-120001193125-24-275844EDGAR6K words

73 total filings indexed. 46 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ARGX — ARGENX SE

Tags

relapsed/refractory-multiple-myeloma acute-myeloid-leukemia-(aml) myelodysplastic-syndrome-(mds) autoimmune-diseases-(generalized-myasthenia-gravis) solid-tumors-(small-cell-lung-cancer,-hepatocellular-carcinoma) hematologic-cancers 2016-international-myeloma-working-group-(imwg)-uniform-response-criteria eastern-cooperative-oncology-group-(ecog)-performance-status-scale mrd-negative-assessment-at-10^-5-and-10^-6-sensitivity

Company Identity

CIK0001786205
TickerACLX
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: db9997e04108110a3934b43ca4b5e665fce5e6343eef0c325d0462db28185dc5
parent: db95371ab96eed212729551e23f99c13dbe71b73d037e4af9a7de8068123dbd9
content hash: b31cd6dc9a4fe1311e660dd7f8e86c344a5f07e8b19011c5b1045bbf02ab385e
signed: 2026-09-29T12:00:07.558Z
sources: 18 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up ACLX using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on ACLX, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/ACLX (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.